학술논문

Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors

Document Type

Article

Author

Ochsenreither, S.; Fiedler, W.M.; Conte, G.D.; Macchini, M.; Matos, I.; Habel, B.; Ahrens-Fath, I.; Raspagliesi, F.; Lorusso, D.; Keilholz, U.; Rolling, C.; Kebenko, M.; Klinghammer, K.F.; Saavedra, O.; Baumeister, H.; Zurlo, A.; Garralda, E.

Source

In ESMO Open April 2022 7(2)

Subject

Phase I Trials

Language

ISSN

2059-7029

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Full Text (ScienceDirect O/A) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송